Aptabridge Therapeutics
PrivateLast Round
Grant
Jun 16, 2023
Total Funding Raised
$103,000
Company Overview
Aptabridge Therapeutics operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Grant round in June 2023.
Aptabridge Therapeutics is a biotechnology company that develops a drug design platform leveraging DNA nanoparticles for immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aptabridge Therapeutics Comparables
Compare Aptabridge Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DoriNano | 79% | |
| Aptadel Therapeutics | 77% | |
| NextRNA Therapeutics | 73% |
For institutional investors. Book with your work email.
Aptabridge Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 16, 2023 | ||||
| Seed | May 16, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aptabridge Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Johns Hopkins University Endowment | Grant |
| FastForward U | Seed |
| HopStone Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2023
$100K grant from Johns Hopkins University Endowment
- May 16, 2023
$3K round from FastForward U and HopStone Capital.
For institutional investors. Book with your work email.
Aptabridge Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aptabridge Therapeutics's valuation, stock price, and market status.
Is Aptabridge Therapeutics a public or private company?
Aptabridge Therapeutics is a private company.
What is the current stock price of Aptabridge Therapeutics?
Aptabridge Therapeutics is a private company, so its shares have no public market price. Caplight tracks Aptabridge Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aptabridge Therapeutics worth (valuation)?
Valuation information for Aptabridge Therapeutics is not publicly available.
Can I buy Aptabridge Therapeutics stock?
Aptabridge Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aptabridge Therapeutics's last funding round?
Aptabridge Therapeutics's most recent funding round was Grant on June 16, 2023.
Who are the main investors in Aptabridge Therapeutics?
Key investors in Aptabridge Therapeutics include Johns Hopkins University Endowment, FastForward U, HopStone Capital.
Will Aptabridge Therapeutics IPO soon?
No public IPO plans have been announced for Aptabridge Therapeutics.
How can I track Aptabridge Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Aptabridge Therapeutics's shares on secondary markets.